THRB and metabolic dysfunction-associated steatohepatitis: The therapeutic effects of thyroid hormone receptor beta (THR-β) agonists like TERN-501 in MASH are attributed to their ability to enhance hepatic lipid metabolism through mitochondrial biogenesis and β-oxidation.